<DOC>
	<DOCNO>NCT01705964</DOCNO>
	<brief_summary>Project Aim : To determine intramuscular epinephrine effective adjunct inhale bronchodilator ( β2 agonist ) child severe asthma exacerbation . Hypothesis : IM epinephrine efficacious adjunct inhale bronchodilator ( β2 agonist ) child severe asthma exacerbation . Intervention : Subjects randomly assign ( 50 % chance ) receive weight base dose IM epinephrine 1:1000 adjunctive medication . The dose 0.2 mg subject 20-30 kg 0.3 mg subject great 30 kg . This inject intramuscularly ED nurse anterior thigh muscle subject use 1 ml syringe 23 gauge one inch needle . In addition study intervention , standardize treatment pathway base current asthma guideline use investigator 's center utilize . This pathway include nebulized albuterol , ipratropium bromide , systemic corticosteroid . The duration dosages intervention administer discretion treat provider .</brief_summary>
	<brief_title>Intramuscular Epinephrine Adjunctive Treatment Severe Pediatric Asthma Exacerbation</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>1 . Age great 6 year less 18 year 2 . Preexisting diagnosis asthma 3 . Presenting ED asthma exacerbation 1 . History chronic lung upper airway disease asthma 2 . History significant , uncorrected congenital heart disease cardiac arrhythmia 3 . History thyroid disease 4 . Impending respiratory failure 5 . Allergy epinephrine 6 . Pregnancy 7 . PEFR &gt; 60 % predict clinical asthma score less 8</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Status asthmaticus</keyword>
	<keyword>Asthma exacerbation</keyword>
	<keyword>Epinephrine</keyword>
	<keyword>Adjunctive therapy</keyword>
</DOC>